When to Skip Regional Nodal Radiation in Breast Cancer When to Skip Regional Nodal Radiation in Breast Cancer
When neoadjuvant chemotherapy turns positive lymph nodes negative, 5-year survival outcomes are the same whether patients have regional nodal irradiation or not.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 7, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
SABCS: Neoadjuvant Chemo Can Let Breast Cancer Patients Skip Nodal RT
THURSDAY, Dec. 7, 2023 -- Patients who present with breast cancer with axillary node involvement (cN+) who are found to be pathologically node-negative at surgery (ypN0) after neoadjuvant chemotherapy can avoid regional nodal irradiation (RNI),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 7, 2023 Category: Pharmaceuticals Source Type: news
No Benefit to Adjuvant-Only Immunotherapy in Early TNBC
(MedPage Today) -- SAN ANTONIO -- Adjuvant-only immunotherapy with atezolizumab (Tecentriq) added to a standard chemotherapy backbone failed to improve invasive disease-free survival (iDFS) compared with chemotherapy alone in patients with early... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 7, 2023 Category: Hematology Source Type: news
De-Escalating Breast Cancer Treatment Feasible After Response to Neoadjuvant Chemo
(MedPage Today) -- SAN ANTONIO -- Omitting regional nodal irradiation (RNI) did not increase the risk of disease progression or death in patients whose breast cancer changed from lymph node-positive to lymph node-negative after neoadjuvant chemotherapy... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 7, 2023 Category: Hematology Source Type: news
DCE-MRI shows treatment response for triple-negative breast cancer
Dynamic contrast-enhanced MRI (DCE-MRI) performs well in predicting early response to immunochemotherapy in women with triple-negative breast cancer, according to a study presented December 6 at the San Antonio Breast Cancer Symposium.
Tumor volume reduction shown on DCE-MRI early into neoadjuvant immunochemotherapy regimens can predict treatment response in these women, said Gaiane Rauch from the University of Texas MD Anderson Cancer Center in Houston in her presentation.
“Higher accuracy of prediction was seen after four cycles of treatment than after two cycles of neoadjuvant immunochemotherapy,” Rauch said.
The...
Source: AuntMinnie.com Headlines - December 7, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Breast Source Type: news
Venus Remedies gets marketing authorisation from Philippines, Saudi Arabia for three oncology drugs
Pharma major Venus Remedies on Wednesday said it has received marketing authorisation from Philippines and Saudi Arabia for three oncology drugs. In a statement, the Panchkula-based company said it has received regulatory approval from Philippines, the second largest market in the Association of Southeast Asian Nations (ASEAN) region, for chemotherapy drug paclitaxel and zoledronic acid. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 6, 2023 Category: Pharmaceuticals Source Type: news
Addressing Chemo-Related Amenorrhea in Early BRCA Addressing Chemo-Related Amenorrhea in Early BRCA
Persistent chemotherapy-related amenorrhea (CRA) after treatment for breast cancer was common and associated with worse long-term quality of life among premenopausal women.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 5, 2023 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia
The new colony-stimulating factor from China proved comparable to pegfilgrastim (Neulasta) in clinical testing.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
Walmart, Target and Walgreens have a second theft problem
Sometimes the solution to a problem can make things worse. That's true in the case of some of the most severe diseases humans have to deal with. The cures for cancer — radiation and chemotherapy — bombard your body with poison to kill the cancer cells. The problem is that those treatments don't…#walmart #wmt #target #targetandwalmart #walmarttargettgt #advantagesolutions #q3outlook #wba #amazon #actionalertsplus (Source: Reuters: Health)
Source: Reuters: Health - November 28, 2023 Category: Consumer Health News Source Type: news
Suicide, Another Face of the Crisis in Venezuela
Suicide rates doubled in Venezuela during the harshest years of its humanitarian crisis. Males between the ages of 30 and 50, a productive age when it is very hard to be left without employment and income, are a group particularly vulnerable to self-inflicted violence. CREDIT: IhpiBy Humberto MárquezCARACAS, Nov 28 2023 (IPS) In the wee hours of one morning in early November, Ernesto, 50, swallowed several glasses of a cocktail of drugs and alcohol in the apartment where he lived alone in the Venezuelan capital, ending a life tormented by declining health and lack of resources to cope as he would have liked.
In the last m...
Source: IPS Inter Press Service - Health - November 28, 2023 Category: International Medicine & Public Health Authors: Humberto Marquez Tags: Development & Aid Economy & Trade Editors' Choice Featured Financial Crisis Headlines Health Humanitarian Emergencies Latin America & the Caribbean Population Poverty & SDGs Regional Categories Suicide Venezuela Source Type: news
Mortality Higher for Black Patients Receiving Neoadjuvant Chemo for Breast Cancer
MONDAY, Nov. 27, 2023 -- For patients with early-stage breast cancer treated with neoadjuvant chemotherapy (NACT), Blacks have higher mortality risk than Whites, according to a study published online Nov. 22 in JAMA Network Open.
Arya Mariam Roy,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 27, 2023 Category: Pharmaceuticals Source Type: news
This commonly prescribed cancer drug was supposed to help save his life, instead it killed him
After being diagnosed with colon cancer earlier this year, Dr. Anil Kapoor of Ontario was prescribed the common chemotherapy medication Fluorouracil. Three weeks later, he died from a toxic reaction to it. His brothers are on a mission to uncover who is most at risk and what the Canadian health-care system should do about it. (Source: CBC | Health)
Source: CBC | Health - November 27, 2023 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news
AI may spare breast cancer patients unnecessary treatments
A new AI (Artificial Intelligence) tool may make it possible to spare breast cancer patients unnecessary chemotherapy treatments by using a more precise method of predicting their outcomes, reports a new Northwestern Medicine study.
AI evaluations of patient tissues were better at predicting the future course of a patient’s disease than evaluations performed by expert pathologists. (Source: World Pharma News)
Source: World Pharma News - November 27, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
This commonly prescribed cancer drug was supposed to help save his life. Instead, it killed him
After being diagnosed with colon cancer earlier this year, Dr. Anil Kapoor of Ontario was prescribed the common chemotherapy medication Fluorouracil. Three weeks later, he died from a toxic reaction to it. His brothers are on a mission to uncover who is most at risk and what the Canadian health-care system should do about it. (Source: CBC | Health)
Source: CBC | Health - November 27, 2023 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news
This commonly prescribed cancer drug was supposed to help save this doctor's life. Instead, it killed him
After being diagnosed with colon cancer earlier this year, Dr. Anil Kapoor of Ontario was prescribed the common chemotherapy medication Fluorouracil. Three weeks later, he died from a toxic reaction to it. His brothers are on a mission to uncover who is most at risk and what the Canadian health-care system should do about it. (Source: CBC | Health)
Source: CBC | Health - November 27, 2023 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news
